Biocon Limited — Insider Trade, 06-01-2026: Insider/ Institutional Trade

Mylan Inc., an institutional investor, has acquired 9,19,67,019 equity shares of Biocon Limited via a preferential allotment. This transaction significantly increases Mylan's stake in Biocon, moving from Nil to 6.10% of the total diluted share capital. This highlights a notable investment by a non-promoter entity.